Evaxion A/S (EVAX)
NASDAQ: EVAX · Real-Time Price · USD
3.300
-0.180 (-5.17%)
At close: Feb 20, 2026, 4:00 PM EST
3.350
+0.050 (1.52%)
After-hours: Feb 20, 2026, 4:00 PM EST
Evaxion Market Cap
Evaxion has a market cap or net worth of $27.44 million as of February 20, 2026. Its market cap has increased by 46.44% in one year.
Market Cap
27.44M
Enterprise Value
16.87M
1-Year Change
46.44%
Ranking
Category
Stock Price
$3.30
Market Cap Chart
Since the IPO on February 5, 2021, Evaxion's market cap has decreased from $191.99M to $27.44M, a decrease of -85.71%. That is a compound annual growth rate of -32.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 27.44M | -31.03% |
| Dec 31, 2025 | 39.78M | 702.21% |
| Dec 31, 2024 | 4.96M | -80.92% |
| Dec 29, 2023 | 25.99M | -39.34% |
| Dec 30, 2022 | 42.84M | -58.12% |
| Dec 31, 2021 | 102.29M | -46.72% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lantern Pharma | 29.19M |
| Reviva Pharmaceuticals Holdings | 28.86M |
| Dyadic International | 28.77M |
| AN2 Therapeutics | 28.50M |
| Hyperion DeFi | 27.63M |
| Passage Bio | 27.37M |
| Rallybio | 26.72M |
| Lixte Biotechnology Holdings | 26.49M |